Titlebook: Neurodegenerative Diseases; Clinical Aspects, Mo Daniela Galimberti,Elio Scarpini Book 20141st edition Springer-Verlag London 2014 Alzheime

dentin

書目名稱Neurodegenerative Diseases影響因子(影響力)




書目名稱Neurodegenerative Diseases影響因子(影響力)學(xué)科排名




書目名稱Neurodegenerative Diseases網(wǎng)絡(luò)公開度




書目名稱Neurodegenerative Diseases網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Neurodegenerative Diseases被引頻次




書目名稱Neurodegenerative Diseases被引頻次學(xué)科排名




書目名稱Neurodegenerative Diseases年度引用




書目名稱Neurodegenerative Diseases年度引用學(xué)科排名




書目名稱Neurodegenerative Diseases讀者反饋




書目名稱Neurodegenerative Diseases讀者反饋學(xué)科排名

本能

知識分子

Book 20141st editionar degeneration, amyotrophic lateral sclerosis, and additional neurodegenerative diseases. Different aspects of each disease are reviewed, including clinical issues, treatments, basic discoveries (genetics and molecular biology), and translation of basic research into biomarkers for early diagnosis.

威脅你

產(chǎn)生

,Alzheimer’s Disease and Frontotemporal Lobar Degeneration: Mouse Models,have seen the identification of new genes involved in the disease. This led to the generation of a large number of new transgenic mouse models for FTLD. This chapter provides an overview of APP and tau-based mouse models of AD and FTLD and discusses in detail the more recent FTLD models expressing novel disease genes.

脆弱帶來

Amyotrophic Lateral Sclerosis: Genotypes and Phenotypes,notypes. This information is essential for biologists and clinicians alike, providing at the same time an unparalleled insight into the pathogenesis of the disease and invaluable tools for genetic counseling, diagnosis, and development of preventive strategies and treatments for ALS.

大量

Neurodegeneration and Multiple Sclerosis,d Parkinson’s disease, as well as multiple sclerosis (MS), diabetes, acute brain injury among many other conditions. This chapter discusses the clinical and pathophysiological features of neurodegeneration in MS.

FLAG

correspondent

,Alzheimer’s Disease: Clinical Aspects and Treatments,biological biomarkers, in particular radiological and cerebrospinal fluid Amyloid, tau and phospho-tau levels. Here, the main clinical aspects and diagnostic tools for AD are revised; atypical AD presentations and possible diagnostic pitfalls are also discussed.

相互影響

,Autosomal Dominant Alzheimer’s Disease: Underlying Causes,rk (DIAN). We provide an overview for the molecular genetic findings available for causal AD genes, discuss how this knowledge can be applied in clinical practice, and highlight the strategies to detect novel AD genes (e.g., . and .).